Sep 11, 2015 - Benchmarks ended modestly higher on Thursday amid rise in oil prices and uncertainty about the timing of a rate hike
Sep 11, 2015 - Amgen ([[AMGN]] -0.8%) files an application with the FDA seeking clearance for a single once-per-month 420 mg injection of its cholesterol fighter Repatha
Sep 11, 2015 - AstraZeneca (AZN) purchases a biologics bulk manufacturing facility from Amgen (AMGN) for an undisclosed sum. The site, located in Boulder, CO, will eventu
Sep 11, 2015 - The past ten days has brought continued good fortune for AstraZeneca.Brilinta received approval based on positive outcomes data.The article below builds off my previously posted work on the company.
Sep 10, 2015 - Now that Amgen and Regeneron-Sanofi have their new cholesterol-lowering drugs on the market, the Street is trying to get a better handle on future profits from these drugs.UBS has moved toward my long
Sep 10, 2015 - The Zacks Analyst Blog Highlights: Amgen, Tetraphase, Geron, Alexion and ACADIA
Sep 09, 2015 -
Sep 09, 2015 - What will be the impact of biosimilar competition on Amgen's (AMGN) Neupogen now that Zarxio has been launched in the U.S.?
Sep 09, 2015 - Benchmarks ended higher on Tuesday after weak Chinese trade data raised hopes that further stimulus measures will be announced to boost its fragile economy
Sep 09, 2015 - I list the hallmarks used to develop cancer drugs.Biogen enrolls first patient in Phase III trial for aducanumab.GlaxoSmithKline’s Relvar/Breo Ellipta Fails to Meet Primary Endpoint.